Domů › Nemalobuněčný plicní karcinom › Kalifornie › San Diego
Klinické studie Nemalobuněčný plicní karcinom v San Diego, CA
48 studií pro Nemalobuněčný plicní karcinom hledá účastníky v lokalitách v San Diego a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Probíhá náborFáze 2/3
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla · Vzdálenost 11 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Probíhá náborFáze 3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Probíhá náborFáze 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Vzdálenost 11 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Probíhá náborFáze 3
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Probíhá náborFáze 1
- University of California San Diego Moores Cancer Center, San Diego
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Probíhá náborFáze 1
- ALX Center 9, La Jolla · Vzdálenost 11 mi
A Study of PHN-012 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- PHN-012-001 Site, San Diego
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Probíhá náborFáze 2
- University of California at San Diego, La Jolla · Vzdálenost 11 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Probíhá náborFáze 3
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- UCSD Medical Center - Rancho Bernardo, San Diego
- a dalších 3
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Probíhá náborObservační studie
- University of California San Diego, La Jolla · Vzdálenost 11 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- Moores Cancer Center at UC San Diego Health, La Jolla · Vzdálenost 11 mi
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Probíhá náborFáze 2
- University of California San Diego Health, La Jolla · Vzdálenost 11 mi
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Probíhá náborFáze 1/2
- Scripps Clinic Torrey Pines (Scripps Cancer Center), La Jolla · Vzdálenost 11 mi
- Scripps Green Hospital, La Jolla · Vzdálenost 11 mi
- Scripps Shiley Pavilion, La Jolla · Vzdálenost 11 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Kaiser Permanente San Diego Mission Road, San Diego
Pan-tumor MRD Study
Probíhá náborObservační studie
- Medical Oncology Associates of San Diego (MOASD), San Diego
- Medical Oncology Associates of San Diego, San Diego
Intratumoral N17350 in Advanced Solid Tumors
Probíhá náborFáze 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Probíhá náborFáze 2/3
- University Of California - San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Probíhá náborFáze 3
- Clinical Study Site, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Probíhá náborObservační studie
- University of California, San Diego, La Jolla · Vzdálenost 11 mi
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- UCSD Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Probíhá náborFáze 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Probíhá náborFáze 3
- Research Site, San Diego
- Research Site, La Jolla · Vzdálenost 11 mi
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Probíhá náborFáze 1
- University of California - San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Probíhá náborFáze 3
- Sharp Memorial Hospital ( Site 9544), San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Probíhá náborFáze 1
- University of California San Diego, Moores Cancer Center, San Diego
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Probíhá náborFáze 3
- Research Site, San Diego
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Probíhá náborFáze 2
- Kaiser Permanente San Diego Mission Road, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Probíhá náborFáze 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Probíhá náborFáze 1/2
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Probíhá náborFáze 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Probíhá náborFáze 1/2
- University of California, San Diego Moores Cancer Center, San Diego
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Probíhá náborFáze 1/2
- UCSD Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Probíhá náborFáze 1
- University of California San Diego Moores Cancer Center, San Diego
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Probíhá náborFáze 3
- Research Site, San Diego
- Research Site, La Jolla · Vzdálenost 11 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2/3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Probíhá náborFáze 2
- University of California San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Probíhá náborFáze 1/2
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · Vzdálenost 11 mi
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Probíhá náborFáze 1/2
- Research Site, La Jolla · Vzdálenost 11 mi
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Probíhá náborFáze 1/2
- VA San Diego Healthcare System, San Diego, CA, San Diego
Retifanlimab and Ruxolitinib In Solid Malignancies
Probíhá náborFáze 1/2
- University of California, San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, La Jolla · Vzdálenost 11 mi
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Probíhá náborFáze 1/2
- UCSD Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Probíhá náborFáze 1
- UC San Diego Moores Cancer Center, La Jolla · Vzdálenost 11 mi
Studie Nemalobuněčný plicní karcinom v jiných městech
- Houston, TX145 studií
- New York City, NY121 studií
- Arlington, VA104 studií
- Nashville, TN97 studií
- Boston, MA90 studií
- Los Angeles, CA87 studií
- St. Louis, MO73 studií
- Chicago, IL61 studií
- Baltimore, MD60 studií
- San Antonio, TX59 studií
- Columbus, OH57 studií
- Washington, DC55 studií
Další studie v San Diego
- Rakovina prsu41 studií
- Rakovina (všechny typy)32 studií
- Rakovina prostaty31 studií
- Metastatický karcinom30 studií
- Kolorektální karcinom25 studií
- Rakovina vaječníků24 studií
- Rakovina slinivky břišní24 studií
- Rakovina plic23 studií
- Obesity23 studií
- Srdeční selhání23 studií
- Deprese21 studií
- Melanom18 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.